Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...

Scienture shares originally traded higher on Tuesday but have since reversed and began trading lower after the company announced the FDA approved its new drug application for Arbli.

The prevalence of LVH increased progressively across METS-VF quartiles, ranging from 7.9% to 31%. Higher METS-VF levels were ...

Despite having cardiovascular risk factors, asymptomatic aircraft pilots referred for medical screenings demonstrate favorable long-term outcomes and a low risk for major cardiac events.

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...

Imagine receiving a diagnosis that changes your life in an instant: hypertrophic cardiomyopathy, a heart condition that can strike without warning, claiming thousands of lives annually .

Athlete's Heart or Cardiomyopathy: The Diagnostic 'Grey Zones' A common clinical scenario faced by the sports cardiologist is the athlete exhibiting mild LVH in the range of 13–16 mm ...

Lehigh Valley Health Network, part of Jefferson Health, expects to open its fourth neighborhood hospital next year in ...

Division of Cardiology – LVH-Hazleton. “In addition, low physical activity and smoking can increase the likelihood of developing heart disease. We have an aging population and with increasing ...

gmail.com Background Differentiating physiological left ventricular hypertrophy (LVH) in athletes from pathological hypertrophic cardiomyopathy (HCM) can be challenging. This study assesses the ...